Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

All articles by Andrea S. Blevins Primeau, PhD, MBA

General Medicine

Third Dose of COVID-19 Vaccine Increases Neutralizing Antibodies Against Omicron in Cancer Patients

Andrea S. Blevins Primeau, PhD, MBA

February 28, 2022

The proportion of patients with solid tumors who had neutralizing antibodies against the omicron variant rose from 37% after 2 vaccine doses to 90% after 3 doses.